Nearly 4 Billion-Dollar Market for IVD Packaging

Nearly 4 Billion-Dollar Market for IVD Packaging

In vitro diagnostic tests require specialized boxes, bottles, bags and plates to protects crucial chemicals and insure a quality result each time a test is performed. Thus it’s not surprising that growth in IVD drives growth in packaging. That’s the conclusion of The Freedonia Group’s new study, In Vitro Diagnostic Test Packaging. Take two trends for example. The increasing use of point-of-care tests and the development of high-quality molecular testing supplies. Both trends drive more and higher quality packaging.

US demand for IVD packaging products is projected to increase 2.9 percent annually to over $3.9 billion in 2020. Microplates, bottles, stoppers, paperboard boxes and trays are among the items that will witness growth in the next five years, according to the report. The Freedonia Group’s report considered Kalorama Information’s IVD numbers in its analysis. (We note the Freedonia Group is now part of, the parent company of Kalorama Information.). So customers who have purchased Kalorama Information reports will find estimates in line with industry assumptions that we have previously published.

IVD is a growing emphasis in healthcare due to demand for faster diagnosis, volume increases from automation and a more preventative focus in healthcare. The Freedonia group has the market at 3.9 billion. Primary containers will comprise 63 percent of the market. The remainder of demand will be divided among closures, secondary containers, microplates, labels and package inserts, and various other accessories. Over the past several years, advances in reagents and related substances have increased the quality and performance requirements of IVD packaging configurations. This trend is promoting the use of higher value-added containers, closures, and packaging accessories. Nonetheless, the relative cost of packaging to IVD product shipments is expected to gradually decrease. The report details the reason for this trend and provides specific estimates for categories of test packaging.

Included in this end-use product shipment segment are reagent and solution bottles, blood collection tubes, sample and transport tubes, culture and media bottles, tubular vials, culture and media plates, and various miscellaneous containers such as ampuls, bags and pouches, test sticks and blister packs. Based on expanding use in cancer testing and the detection of complex infectious diseases, culture and media plates and bottles will post the fastest revenue growth through 2020 and beyond. However, by 2025 blood collection tubes will capture the largest share of demand value due to their adaptability to virtually all types of IVD procedures as well as to evolving user preferences for higher value-added types with enhanced seals and premium additives.

Reagent and solution bottles will continue to dominate the packaging of consumables for clinical chemistry and immunoassay procedures. The market for IVD closures will continue to be dominated by screw-threaded and stopper configurations. Spurred by the increasing availability of point-of-care test kits, folding paperboard boxes and cartons and trays will generate above average revenue growth. By contrast, the overall market for IVD microplates will expand at a decelerating pace as a number of immunoassays performed in clinical and hospital laboratories are replaced by point-of-care tests and professional molecular diagnostic procedures. Security labels, expanded content package inserts, and intelligent components will generate the fastest sales gains among other IVD packaging products.

Alexander (James) Corporation. Amcor Limited , Duran Group GmbH , GBF Incorporated, Multisorb Technologies Incorporated, Wheaton Industries and WS Packaging Group Incorporated are among the companies competing in this market.